Truly Labs a Partner in a €24 Million European Consortium TRISTAN – Translational Imaging in Drug Safety Assessment
During the coming five years, Truly Labs will together with researchers at Lund University play a significant role in the European project TRISTAN, funded in part by the Innovative Medicines Initiative (IMI). The objective is to develop imaging tools for safety assessment of new drugs and drugs in development, specifically for lung and liver toxicity and bio-distribution of biologics.
With extensive knowledge and experience in translational science, lung biology and development of in vivo models, Truly Labs will be an important contributor to the part of the project focused on lung imaging biomarkers. The preclinical development and qualification of new lung imaging biomarkers will be done in close collaboration with researchers at Lund University and Lund University Bioimaging Center, who have solid expertise in lung imaging as well as state of the art imaging equipment.